TABLE 5.
Site | No. of subjects |
P | |||
---|---|---|---|---|---|
HLA-B* 4001/4001 |
HLA-B* 5602/5602 |
||||
NSa present | NS absent | NS present | NS absent | ||
S 21 | 2 | 8 | 6 | 1 | 0.02 |
E 77 | 7 | 3 | 1 | 6 | 0.05 |
E 113 | 8 | 2 | 0 | 7 | 0.002 |
NS, nonsynonymous mutations.
Site | No. of subjects |
P | |||
---|---|---|---|---|---|
HLA-B* 4001/4001 |
HLA-B* 5602/5602 |
||||
NSa present | NS absent | NS present | NS absent | ||
S 21 | 2 | 8 | 6 | 1 | 0.02 |
E 77 | 7 | 3 | 1 | 6 | 0.05 |
E 113 | 8 | 2 | 0 | 7 | 0.002 |
NS, nonsynonymous mutations.